Becton, Dickinson and Company (BDX) Position Maintained by State Farm Mutual Automobile Insurance Co.

State Farm Mutual Automobile Insurance Co. held its stake in Becton, Dickinson and Company (NYSE:BDX) during the first quarter, according to its most recent filing with the SEC. The fund owned 190,800 shares of the medical instruments supplier’s stock at the end of the first quarter. State Farm Mutual Automobile Insurance Co. owned approximately 0.09% of Becton, Dickinson and worth $35,000,000 as of its most recent filing with the SEC.

Several other hedge funds have also recently added to or reduced their stakes in the company. North Star Investment Management Corp. boosted its stake in Becton, Dickinson and by 3.4% in the first quarter. North Star Investment Management Corp. now owns 549 shares of the medical instruments supplier’s stock valued at $101,000 after buying an additional 18 shares during the period. Crestwood Advisors Group LLC purchased a new stake in Becton, Dickinson and during the first quarter valued at $101,000. Parkside Financial Bank & Trust boosted its stake in Becton, Dickinson and by 1.4% in the first quarter. Parkside Financial Bank & Trust now owns 633 shares of the medical instruments supplier’s stock valued at $116,000 after buying an additional 9 shares during the period. Financial Architects Inc boosted its stake in Becton, Dickinson and by 62.7% in the first quarter. Financial Architects Inc now owns 677 shares of the medical instruments supplier’s stock valued at $124,000 after buying an additional 261 shares during the period. Finally, QCI Asset Management Inc. NY boosted its stake in Becton, Dickinson and by 9.2% in the first quarter. QCI Asset Management Inc. NY now owns 710 shares of the medical instruments supplier’s stock valued at $130,000 after buying an additional 60 shares during the period. Institutional investors own 75.42% of the company’s stock.

Becton, Dickinson and Company (NYSE BDX) opened at 205.30 on Friday. Becton, Dickinson and Company has a 1-year low of $161.29 and a 1-year high of $205.73. The company has a 50 day moving average price of $195.21 and a 200-day moving average price of $184.45. The firm has a market capitalization of $43.79 billion, a price-to-earnings ratio of 34.10 and a beta of 1.05.

Becton, Dickinson and (NYSE:BDX) last posted its quarterly earnings results on Tuesday, May 2nd. The medical instruments supplier reported $2.30 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.23 by $0.07. Becton, Dickinson and had a return on equity of 25.37% and a net margin of 10.67%. The business had revenue of $2.97 billion for the quarter, compared to analyst estimates of $2.92 billion. During the same period last year, the company earned $2.18 EPS. Becton, Dickinson and’s revenue for the quarter was down 3.2% compared to the same quarter last year. On average, analysts forecast that Becton, Dickinson and Company will post $9.45 EPS for the current fiscal year.

The business also recently declared a quarterly dividend, which was paid on Friday, June 30th. Investors of record on Friday, June 9th were given a dividend of $0.73 per share. The ex-dividend date was Wednesday, June 7th. This represents a $2.92 annualized dividend and a yield of 1.42%. Becton, Dickinson and’s payout ratio is 48.26%.

ILLEGAL ACTIVITY NOTICE: This article was first published by Stock Observer and is owned by of Stock Observer. If you are reading this article on another domain, it was copied illegally and reposted in violation of United States and international copyright & trademark laws. The correct version of this article can be read at https://www.thestockobserver.com/2017/07/22/becton-dickinson-and-company-bdx-position-maintained-by-state-farm-mutual-automobile-insurance-co.html.

Several research firms have recently weighed in on BDX. Zacks Investment Research upgraded Becton, Dickinson and from a “hold” rating to a “buy” rating and set a $225.00 price target on the stock in a report on Monday, July 17th. BidaskClub upgraded Becton, Dickinson and from a “buy” rating to a “strong-buy” rating in a report on Tuesday, July 11th. Cowen and Company restated an “outperform” rating and set a $230.00 price target (up from $200.00) on shares of Becton, Dickinson and in a report on Monday, July 10th. Bank of America Corporation restated a “buy” rating and set a $225.00 price target (up from $200.00) on shares of Becton, Dickinson and in a report on Friday. Finally, Royal Bank Of Canada restated a “hold” rating and set a $177.00 price target on shares of Becton, Dickinson and in a report on Thursday, April 13th. One research analyst has rated the stock with a sell rating, three have given a hold rating, eight have issued a buy rating and two have given a strong buy rating to the company’s stock. Becton, Dickinson and has an average rating of “Buy” and an average price target of $194.69.

In related news, VP Jeffrey S. Sherman sold 28,765 shares of the firm’s stock in a transaction that occurred on Thursday, May 25th. The stock was sold at an average price of $185.98, for a total transaction of $5,349,714.70. Following the transaction, the vice president now directly owns 70,821 shares in the company, valued at approximately $13,171,289.58. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink. 1.40% of the stock is owned by company insiders.

About Becton, Dickinson and

Becton, Dickinson and Company (BD) is a global medical technology company engaged in the development, manufacture and sale of a range of medical supplies, devices, laboratory equipment and diagnostic products. The Company operates through two segments: BD Medical and BD Life Sciences. The BD Medical segment produces an array of medical technologies and devices that are used to help improve healthcare delivery in a range of settings.

Want to see what other hedge funds are holding BDX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Becton, Dickinson and Company (NYSE:BDX).

Institutional Ownership by Quarter for Becton, Dickinson and (NYSE:BDX)

Receive News & Ratings for Becton Dickinson and Company Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Becton Dickinson and Company and related companies with MarketBeat.com’s FREE daily email newsletter.

LEAVE A REPLY

Please enter your comment!
Please enter your name here

five − 2 =